Live Breaking News & Updates on Psybio Shares

Stay updated with breaking news from Psybio shares. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PsyBio Therapeutics Announces Retention of Market Maker


PsyBio Therapeutics Announces Retention of Market Maker
March 04, 2021 08:08 ET
| Source:
PsyBio Therapeutics Corp.
PsyBio Therapeutics Corp.
TORONTO, March 04, 2021 (GLOBE NEWSWIRE) PsyBio Therapeutics Corp. (TSXV:PSYB) (“
PsyBio” or the “
Company”), a leader in the field of psychedelic research and drug development, announces that, subject to the receipt of approval by the TSX Venture Exchange (“
TSXV”), it has retained Generation IACP Inc. (“
Generation”) to provide market making services with the objective of maintaining a reasonable market and improving the liquidity of PsyBio shares traded on the TSXV. PsyBio and Generation are unrelated and unaffiliated entities. Generation is a member of the Investment Industry Regulation Organization of Canada (IIROC) and a member firm of the TSXV. ....

Kirsten Frazer , Evan Levine , Psybio Therapeutics Corp , Lifesci Communications , Investment Industry Regulation Organization , Drug Administration , Company The Generation Agreement , Regulation Services Provider , Venture Exchange , Bio Therapeutics , Note Regarding , Psybio Shares , Psybio Therapeutics , Tsx Venture Exchange Psyb , கர்ஸ்டந் ஃப்ரேசர் , எவன் லெவின் , முதலீடு தொழில் ஒழுங்குமுறை ஆர்கநைஸேஶந் , ஒழுங்குமுறை சேவைகள் வழங்குநர் , துணிகர பரிமாற்றம் , உயிர் சிகிச்சை , குறிப்பு தொடர்பாக ,

PsyBio Completes Reverse Take-Over Transaction


PsyBio Completes Reverse Take-Over Transaction
Common Shares Expected to Commence Trading on the TSX Venture Exchange Imminently
February 19, 2021 15:17 ET
| Source:
PsyBio Therapeutics Corp.
PsyBio Therapeutics Corp.
Not for distribution to United States newswire services or for release publication, 
distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States.
TORONTO, Feb. 19, 2021 (GLOBE NEWSWIRE) PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) (the “
Company”), announces that it has completed its previously announced reverse takeover of PsyBio Therapeutics, Inc. (“
PsyBio”), a biotechnology company developing a new class of drugs intended for the treatment of mental health challenges and other disorders (the “ ....

United States , United Kingdom , Miami University , Nitin Kaushal , Gerry Goldberg , Noah Davis , Evan Levine , Cross Carmel , Us Exchange , Company Subordinate Voting , Eluss Inc , Bc Ltd , Psybio Therapeutics Financing Inc , Venture Exchange , Regulation Services Provider , National Instrument , Company Amendments , Canaccord Genuity Corp , Company Qualifying Transaction , Psybio Therapeutics Inc , Drug Administration , Psybio Therapeutics Corp , Company Bc Sub , Company Us Sub , Leo Acquisitions Corp The Company , Bio Therapeutics ,